LMG Life Sciences 2022 Recognizes Gibson Dunn in Six Practices and Names 13 Lawyers Stars

September 21, 2022

The 2022 edition of LMG Life Sciences highlighted six Gibson Dunn practices – Antitrust, Corporate, General Patent Litigation, Mergers and Acquisitions, Hatch-Waxman Patent Litigation (Branded), and White-Collar/Government Investigations – in the area of Life Sciences. Additionally, the guide noted 13 Gibson Dunn lawyers as “Life Science Stars” including Managing Partner Barbara Becker; Century City partner Wayne Barsky; New York partners Reed Brodsky, Charlotte Jacobsen, Jane LoveDaniel Thomasch, and Robert Trenchard; Orange County partner Jeffrey Thomas; Palo Alto partners Joseph Barbeau and Jessica Valenzuela; and San Francisco partners Winston ChanRyan Murr, and Karen Spindler. The rankings were published on September 21, 2022.

The Life Sciences Practice Group represents and advises innovative biotechnology, pharmaceutical and medical device companies on a wide range of legal, regulatory and strategic issues, including patent and product liability litigation, U.S. Food and Drug Administration (FDA) investigations and enforcement actions, and corporate transactions and financings. Many Gibson Dunn lawyers hold advanced scientific degrees and have hands-on experience working in life sciences companies or within the government agencies that regulate the industry.